ArticleVaccines2025

Active Surveillance of Adverse Events Following Influenza Immunization in Jiangsu Province, China: A 2019-2023 Retrospective Study.

Zhiguo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.